BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11401949)

  • 21. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.
    Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J
    J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can adenosine triphosphate induce maximal hyperemic response in patients with impaired coronary microcirculation?: comparison of hyperemic response to adenosine triphosphate administered by intravenous and by intracoronary injection using Doppler guide wire].
    Yanagi S; Hirota K; Nagae K; Abe Y; Hasegawa T; Okada M; Ota T; Yoshikawa J
    J Cardiol; 2002 Jan; 39(1):1-10. PubMed ID: 11828792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
    Duconge J; Miranda-Massari JR; Gonzalez MJ; Jackson JA; Warnock W; Riordan NH
    P R Health Sci J; 2008 Mar; 27(1):7-19. PubMed ID: 18450228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic perspectives on megadoses of ascorbic acid.
    Blanchard J; Tozer TN; Rowland M
    Am J Clin Nutr; 1997 Nov; 66(5):1165-71. PubMed ID: 9356534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and impact of vitamin C in clinical nutrition.
    McGregor GP; Biesalski HK
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):697-703. PubMed ID: 17053422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.
    Hoffer LJ; Robitaille L; Zakarian R; Melnychuk D; Kavan P; Agulnik J; Cohen V; Small D; Miller WH
    PLoS One; 2015; 10(4):e0120228. PubMed ID: 25848948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New oral liposomal vitamin C formulation: properties and bioavailability.
    Łukawski M; Dałek P; Borowik T; Foryś A; Langner M; Witkiewicz W; Przybyło M
    J Liposome Res; 2020 Sep; 30(3):227-234. PubMed ID: 31264495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of smoking on erythorbic acid pharmacokinetics.
    Lykkesfeldt J; Bolbjerg ML; Poulsen HE
    Br J Nutr; 2003 May; 89(5):667-71. PubMed ID: 12720586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamins C and E and the prevention of preeclampsia.
    Padayatty SJ; Levine M
    N Engl J Med; 2006 Sep; 355(10):1065; author reply 1066. PubMed ID: 16957157
    [No Abstract]   [Full Text] [Related]  

  • 30. Statins and antioxidant vitamins: should co-administration be avoided?
    Tousoulis D; Antoniades C; Stefanadis C
    J Am Coll Cardiol; 2006 Mar; 47(6):1237; author reply 1237-8. PubMed ID: 16545666
    [No Abstract]   [Full Text] [Related]  

  • 31. From scurvy to sepsis: vitamin C--A pill for all seasons?
    Lehmann C; Usichenko TI; Pavlovic D
    Crit Care Med; 2005 Aug; 33(8):1881-2. PubMed ID: 16096480
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers.
    Mühlhöfer A; Mrosek S; Schlegel B; Trommer W; Rozario F; Böhles H; Schremmer D; Zoller WG; Biesalski HK
    Eur J Clin Nutr; 2004 Aug; 58(8):1151-8. PubMed ID: 15054428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin C pharmacokinetics: implications for oral and intravenous use.
    Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
    Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of positron emission tomography in the investigation of human coronary circulatory function.
    de Silva R; Camici PG
    Cardiovasc Res; 1994 Nov; 28(11):1595-612. PubMed ID: 7842452
    [No Abstract]   [Full Text] [Related]  

  • 35. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women.
    Kushi LH; Folsom AR; Prineas RJ; Mink PJ; Wu Y; Bostick RM
    N Engl J Med; 1996 May; 334(18):1156-62. PubMed ID: 8602181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summaries for patients. How vitamin C is administered affects how much reaches the bloodstream and may affect the results of studies of its potential effect on cancer.
    Ann Intern Med; 2004 Apr; 140(7):I61. PubMed ID: 15069006
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute effect of oral vitamin C on coronary circulation in young healthy smokers.
    Teramoto K; Daimon M; Hasegawa R; Toyoda T; Sekine T; Kawata T; Yoshida K; Komuro I
    Am Heart J; 2004 Aug; 148(2):300-5. PubMed ID: 15309000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To C or not to C, that is the question!
    Frei B
    J Am Coll Cardiol; 2003 Jul; 42(2):253-5. PubMed ID: 12875760
    [No Abstract]   [Full Text] [Related]  

  • 39. Antioxidant vitamins in the prevention of cardiovascular disease. The epidemiological evidence.
    Price JE; Fowkes FG
    Eur Heart J; 1997 May; 18(5):719-27. PubMed ID: 9152642
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?].
    Leschke M; Höffken H; Schmidtsdorff A; Blanke H; Egbring R; Joseph K; Strauer BE
    Dtsch Med Wochenschr; 1989 Jun; 114(24):939-44. PubMed ID: 2731478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.